The pet calming supplement market is evolving fast, moving away from one-off sedatives and toward daily, science-backed solutions. One of the biggest innovations is the introduction of a GABA-producing probiotic for dogs. Here's what's driving the shift, and why LP815 is becoming the ingredient forward-thinking brands are building around.
Estimated reading time: 7 minutes
Key Takeaways: GABA-Producing Probiotic for Dogs
- The pet calming supplement market is shifting to daily, science-backed solutions, moving away from one-off sedatives.
- Consumer demand for preventive wellness drives this change, with pet owners seeking daily supplements that support behavior.
- LP815, a GABA-producing probiotic strain, is central to this new formulation strategy, targeting baseline anxiety rather than just situational stress.
- First-mover advantage exists for those investing in LP815-based products, as the calming supplement space is becoming increasingly competitive.
Is the calming supplement category actually changing, or is it just hype?
The calming supplement category is undergoing a genuine structural shift. Moving away from situational, event-driven products toward science-backed, daily-use solutions rooted in the gut microbiome.
The calming supplement aisle used to be simple. Grab some melatonin, throw in some chamomile, and move on. That era is wrapping up faster than most brands realize.
Pet owners now focus on preventive wellness rather than just treating symptoms, leading to daily supplement routines for their pets. This shift means formulating for long-term daily use alongside situational stress support, using ingredients pet parents recognize and trust. ¹
Meet Rue.🐾 She was a participant in our at-home clinical trial. LP815 helped her embrace a calmer demeanor, which has allowed her to be more social than ever before!
Read her full testimonial here.
What's actually driving the calming market shift for pet supplements?
Consumer behavior and global market data are converging to push the canine calming supplement space toward daily-use, science-backed ingredients. The global calming pet supplements market reached $1.32 billion in 2024. It's projected to grow at a CAGR of 7.1% through 2033, reaching an estimated $2.47 billion. Much of this growth is fueled by the rising prevalence of anxiety-related disorders in pets and the growing demand for natural, science-backed solutions. ²
The ingredients dominating older formulas, such as valerian root, melatonin, and chamomile, are great for what they were intended for: event-driven use cases, like fireworks and vet visits. However, pet parents are shifting their approach to calming. They are seeking a more preventative, daily solution to support their pets behavior on a consistent basis.
Certain probiotic strains, like LP815, are now emerging as formulation targets specifically for their ability to support calm behavior through the gut-brain axis. This is a growing focus for brands leaning into the science of emotional wellness in dogs. ¹
Why is the gut-brain axis becoming a core formulation strategy for canine calming?
The canine gut-brain axis is shifting from a talking point to a formulation criterion because it offers something other calming ingredients can't: a mechanism that addresses the root conditions of canine anxiety rather than masking its symptoms. Leading brands are now building products around the gut-brain axis as a foundation for canine emotional wellness formulations.¹
This connection is significant for calming specifically because it reframes where anxiety is addressed. Rather than modulating a single receptor or flooding the system with sedating compounds, the gut-brain approach works upstream. By supporting calm from within, the nervous system can better self-regulate.
GABA (gamma-aminobutyric acid) is central to this story. It's the nervous system's primary inhibitory neurotransmitter, the biological "brake" on anxiety, reactivity, and stress. Compounds that increase GABA production in the brain are drawing attention as a more targeted approach to canine stress management. Most calming products reference GABA, yet very few actually produce it where it matters: the gut microbiome. ³
What are leading pet brands doing differently with LP815?
The brands getting ahead in canine calming are building formulations around LP815, a GABA-producing probiotic designed to create a 'GABA Factory' in the gut. This ongoing biological process supports the gut-brain axis from within. It's GRAS, allergen-free, and Non-GMO Project Verified, with clinical data behind it.
For canine applications, this creates differentiation that's genuinely hard to replicate with commodity calming stacks:
Daily use is the point, not a workaround. LP815 is built for routine. This isn't an ingredient to give before fireworks and forget. It's an ingredient that works because it's given every day. For brands trying to win on repeat purchases, LP815 is a smart addition to daily behavior supporting supplements.
It targets baseline anxiety, not just spikes. The category has been almost entirely event-focused. LP815 supports what many pet owners actually struggle with most: the dog that's always a little reactive or a little nervous. Most dogs don't have a fireworks problem. Rather, they struggle with nervous system regulation.
It differentiates at the mechanism level. Anyone can put "calming" on a label. Far fewer brands can say their product works through a validated, living biological process that produces GABA endogenously in the gut.
How Long Does the Formulation Window Stay Open?
The window for first-mover advantage in science-backed, gut-brain-axis canine calming is open right now, but category transitions move faster than most brands expect. The gut-brain axis positioning is real, it's growing, and it's starting to attract formulation investment from brands not previously in the calming space, which means the category is about to get more competitive.
The brands that move now to develop a clinical story and craft consumer messaging around LP815 may hold a meaningful advantage. The brands that wait will be playing catch-up in a more expensive, more competitive market.
For those seeking canine supplement formulation ideas for LP815, here is what Verb recommends:
- Daily functional treats. The natural application for a daily-use behavioral wellness ingredient
- Meal toppers and powdered supplements. A growing segment with strong consumer adoption and clean label appeal
- Functional kibble. Where gut-brain positioning can elevate an entire product line, not just a single SKU
- Multi-benefit stacks. LP815 pairs naturally alongside ingredients like L-theanine, magnesium, or adaptogens for brands building comprehensive behavioral wellness platforms
Ready to Build a Canine Calming Formulation Strategy Around LP815?
LP815 is not a drop-in swap. It's an ingredient that works best when the formulation strategy, product architecture, and brand story are built around what it actually does.
Our team works directly with brands to develop LP815 applications that fit your category, your format, and your consumer base. Whether you're ideating a new SKU, rethinking an existing calming line, or exploring how behavioral wellness fits into a broader pet health platform, we'd like to be in the room.
FAQ: Canine Calming Supplements & LP815
A GABA-producing probiotic for dogs is a specific probiotic strain that, once established in the gut, produces gamma-aminobutyric acid (GABA) through a natural biological process. Unlike calming supplements that deliver GABA as a static ingredient, a GABA-producing probiotic works as an ongoing source, supporting the gut-brain axis and helping regulate stress and anxiety from within. LP815 (Lactiplantibacillus plantarum LP815) is a clinically studied example of this ingredient class, designed specifically for sustained, daily GABA production to support calm behavior in dogs.
Situational calming supplements for dogs are formulated to provide short-term relief before a known stressor, such as fireworks, travel, or a vet visit. A daily calming probiotic, by contrast, works cumulatively over time to support the gut-brain axis and regulate baseline anxiety and stress responses
The gut-brain axis is the bidirectional communication network between the gastrointestinal system and the central nervous system, and it plays a meaningful role in regulating mood, stress response, and behavior in dogs. Research suggests that the gut microbiome influences neurotransmitter activity (including GABA and serotonin) which directly affects how dogs process and respond to stress. An imbalanced gut microbiome can contribute to heightened anxiety, reactivity, and behavioral disregulation. Probiotic strains that positively influence this pathway, such as LP815, are increasingly used as a foundation for daily canine behavioral wellness formulations.
Sources
1. Take a chill Pill: Trends in calming supplements. (2026, May 5). Pet Food Processing. Retrieved May 19, 2026, from https://www.petfoodprocessing.net/articles/20434-take-a-chill-pill-trends-in-calming-supplements
2. Dataintelo, Patel, D., & Dataintelo. (2025, September 30). Calming Pet Supplements Market Research Report 2033. Dataintelo. https://dataintelo.com/report/calming-pet-supplements-market
3. Black, D. (2026, May 4). Calming Supplements for Dogs: A vet approved guide to anxiety relief (2026). Ruff Greens. https://ruffgreens.com/blogs/news/calming-supplements-for-dogs-guide